Success Story: Overcoming RFE to Advance Photonic Biosensing Technologies: NIW Approval Secured for an Electrical Engineering Expert from Bangladesh
Client’s Testimonial:
“I am extremely grateful for the successful approval of my EB-2 National Interest Waiver petition. The RFE process was challenging and required a strong, well-supported response, but the team handled my case with professionalism, attention to detail, and a clear understanding of my work and its national importance. Their guidance and strategic approach gave me confidence throughout the process. Receiving my NIW approval is a significant milestone in my professional and immigration journey, and I sincerely appreciate all the hard work and dedication that went into my case. I highly recommend their services to professionals seeking an EB-2 NIW.”
On August 13th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Sr. Power Systems Engineer in the field of Electrical Engineering (Approval Notice).
General Field: Electrical Engineering
Position at the Time of Case Filing: Sr. Power Systems Engineer
Country of Origin: Bangladesh
State of Residence at the Time of Filing: Michigan
Approval Notice Date: August 13th, 2026
Processing Time: 10 months, 7 days (Premium Processing Requested)
Case Summary:
We are pleased to share the NIW approval of an electrical engineering expert whose work advances next-generation biosensing technologies for improved disease detection and healthcare accessibility. The client’s proposed endeavor focuses on designing photonic crystal fiber-based biosensors that integrate surface plasmon resonance techniques and machine learning algorithms to enable real-time, non-invasive detection of disease biomarkers associated with conditions such as kidney disease, liver disease, diabetes, and anemia. At the time of filing, the client was working as a Sr. Power Systems Engineer while continuing to advance his expertise in photonics, optoelectronic devices, and biosensing technologies.
Research with National Importance
The client’s proposed endeavor addresses critical healthcare challenges by improving the accuracy, accessibility, and efficiency of disease detection. By developing highly sensitive biosensing platforms that combine photonic technologies with machine learning, his work supports earlier diagnosis, improved disease monitoring, and expanded access to advanced diagnostic tools. These contributions align with U.S. priorities in healthcare innovation, advanced diagnostics, and emerging technologies.
Academic Contributions and Recognition
At the time of filing, the client’s record included 4 peer-reviewed journal articles (1 first-authored) and 6 peer-reviewed conference articles, with his published work receiving 63 citations. His contributions include designing advanced photonic crystal fiber structures for optical applications and developing biosensing approaches integrating surface plasmon resonance and machine learning techniques.
His publications have appeared in recognized venues in electrical engineering and photonics, including a highly ranked journal in the field. His work has been cited by independent researchers studying photonic fiber designs, biosensors, and nonlinear optical technologies, demonstrating the influence of his contributions in advancing photonics research.
Recognition from Experts
Experts highlighted the significance of the client’s contributions to advancing photonic technologies and biomedical diagnostic applications.
One expert noted:
“Clearly, [client]’s skillset is irreplaceable, given its immense benefits to biomedical diagnostics, disease detection, and healthcare innovation. It is imperative that he be allowed to carry out his research uninterrupted so that the United States is able to benefit fully from its value.”
This endorsement reinforces the significance of the client’s expertise and the potential impact of his work on healthcare innovation and diagnostic technologies. Combined with his publication record, citation impact, and documented influence on subsequent research, the expert support further demonstrates his ability to advance photonic biosensing technologies.
NIW Approval and Outlook
The I-140 NIW petition was filed on October 6th, 2025, later upgraded to Premium Processing, and approved on August 13th, 2026. The petition successfully overcame an RFE issued on March 20th, 2026. The approval recognized the national importance of the client’s work in electrical engineering, particularly his efforts to develop photonic crystal fiber-based biosensors that integrate surface plasmon resonance and machine learning techniques for improved early disease detection and healthcare accessibility.
This outcome supports the client’s continued efforts to advance biosensing technologies, optical engineering, and innovative diagnostic solutions in the United States. We congratulate him on this approval and wish him continued success in advancing electrical engineering innovation.